» Articles » PMID: 37610407

New Insights Into Dietary Approaches to Potassium Management in Chronic Kidney Disease

Abstract

Potassium disorders are one of the most common electrolyte abnormalities in patients with chronic kidney disease (CKD), contributing to poor clinical outcomes. Maintaining serum potassium levels within the physiologically normal range is critically important in these patients. Dietary potassium restriction has long been considered a core strategy for the management of chronic hyperkalemia in patients with CKD. However, this has been challenged by recent evidence suggesting a paradigm shift toward fostering more liberalized, plant-based dietary patterns. The advent of novel potassium binders and an improved understanding of gastrointestinal processes involved in potassium homeostasis (e.g., gastrointestinal potassium wasting) may facilitate a paradigm shift and incorporation of heart-healthy potassium-enriched food sources. Nevertheless, uncertainty regarding the risk-benefit of plant-based diets in the context of potassium management in CKD remains, requiring well-designed clinical trials to determine the efficacy of dietary potassium manipulation toward improvement of clinical outcomes in patients with CKD.

Citing Articles

Finerenone in the management of diabetes kidney disease.

De P, Khine M, Frankel A, Goldet G, Banerjee D, Montero R BMC Nephrol. 2025; 26(1):63.

PMID: 39923037 PMC: 11807303. DOI: 10.1186/s12882-025-03985-9.


Hyperkalemia management: a multidisciplinary expert panel's perspective on the role of new potassium binders.

Fonseca C, Garagarza C, Silva G, Caires G, Marques I, Antonio Lopes J Heart Fail Rev. 2024; 30(2):271-286.

PMID: 39604607 PMC: 11802687. DOI: 10.1007/s10741-024-10461-3.


Plant-based diet in hyperkalemic chronic kidney disease patients receiving sodium zirconium cyclosilicate: a feasibility clinical trial.

Avesani C, Heimburger O, Rubin C, Sallstrom T, Faxen-Irving G, Lindholm B Am J Clin Nutr. 2024; 120(3):719-726.

PMID: 39032787 PMC: 11393394. DOI: 10.1016/j.ajcnut.2024.06.025.


Role of Nutrients in Pediatric Non-Dialysis Chronic Kidney Disease: From Pathogenesis to Correct Supplementation.

Padoan F, Guarnaroli M, Brugnara M, Piacentini G, Pietrobelli A, Pecoraro L Biomedicines. 2024; 12(4).

PMID: 38672265 PMC: 11048674. DOI: 10.3390/biomedicines12040911.


A Culturally-Concordant Plant-Based Dietary Pattern for Hispanic/Latine People with Chronic Kidney Disease.

Biruete A, Leal-Escobar G, Espinosa-Cuevas A, Mojica L, Kistler B Nutrients. 2024; 16(5).

PMID: 38474703 PMC: 10934134. DOI: 10.3390/nu16050574.


References
1.
Sumida K, Yamagata K, Kovesdy C . Constipation in CKD. Kidney Int Rep. 2020; 5(2):121-134. PMC: 7000799. DOI: 10.1016/j.ekir.2019.11.002. View

2.
Goraya N, Simoni J, Jo C, Wesson D . Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int. 2014; 86(5):1031-8. DOI: 10.1038/ki.2014.83. View

3.
Barsotti G, Morelli E, Cupisti A, Meola M, Dani L, GIOVANNETTI S . A low-nitrogen low-phosphorus Vegan diet for patients with chronic renal failure. Nephron. 1996; 74(2):390-4. DOI: 10.1159/000189341. View

4.
Butler J, Anker S, Lund L, Coats A, Filippatos G, Siddiqi T . Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. Eur Heart J. 2022; 43(41):4362-4373. PMC: 9622299. DOI: 10.1093/eurheartj/ehac401. View

5.
Sumida K, Dashputre A, Potukuchi P, Thomas F, Obi Y, Molnar M . Laxative Use and Change in Estimated Glomerular Filtration Rate in Patients With Advanced Chronic Kidney Disease. J Ren Nutr. 2020; 31(4):361-369. PMC: 7965788. DOI: 10.1053/j.jrn.2020.08.005. View